Amadeus and Angels Seed Fund
Archangel investors have committed £1m to the Amadeus and Angels Seed Fund, which invests in UK based technology opportunities that can revolutionise markets and that need a seed stage investment to prove out the opportunity. With £10m directly under management Amadeus seeks companies with ambitious teams, powerful ideas and a defensible technology or competitive advantage.
Seraphim Capital is a £30m venture capital Fund in which Archangel investors have committed £1m. The Fund's primary focus is on UK centric companies looking for equity capital of between £0.75 million and £2.0 million. The Fund's unique strength is its network of private investors, a national group consisting of some of the UK's most successful and influential business leaders. These are typically CEOs, Chairmen, non-exec directors and successful entrepreneurs who are re-cycling returns from their own enterprises.
Alpiq acquires Flexitricity Limited, a British market leader in demand response
22 Apr 2014Calcivis® Caries Activity Imaging System Granted CE Mark
Lausanne (Switzerland) - Alpiq has acquired the British company Flexitricity. With this acquisition, Alpiq can support its strategy implementation by gaining access to specialised know-how and new markets in the area of decentralised energy management. Flexitricity is Great Britain’s leader in the management of networked services.
21 Apr 2014Bloxx Awarded International Patents
Edinburgh, 12 February 2014 - Calcivis, a medical devices company focused on revolutionising the management of tooth decay, today announces that its Calcivis® Caries Activity Imaging System has been granted a CE Mark in Europe. A CE Mark is required before a medical device can be marketed in the EU and a number of other countries and signifies that the manufacturer meets the requirements of European legislation.
27 Mar 2014Touch Bionics sales reach £12.3 million in 2013
Bloxx Awarded International Patents for its
Dynamic Real-Time Web Page Categorisation Software
20 Jan 2014PowerPhotonic Signs Partnership Deal in Israel
20 January 2014 – Touch Bionics, a provider of world-leading prosthetic technologies, today announced that preliminary results indicate the company achieved revenue growth of 23% in 2013 to reach £12.3m in total sales.
25 Oct 2013
World leader in precision laser micro-optics expands presence in new markets.